Mode
Text Size
Log in / Sign up

Precocious Puberty

Subtypes of Precocious Puberty

Central precocious puberty 4

8 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Precocious Puberty

6 trials tracked for Precocious Puberty: 4 in phase 3 or 4.

6Trials tracked
4Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 3 4 Phase 2 2
  1. Phase 3 Effects of Triptorelin Pamoate in Children With Precocious Puberty - Follow up Study Completed
  2. Phase 3 Study of Lupron Depot In The Treatment of Central Precocious Puberty Completed
  3. Phase 3 Efficacy and Safety Study of Pamoate of Triptorelin in Children With Precocious Puberty Completed
  4. Phase 3 A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat Central Precocious Puberty Completed
  5. Phase 2 Pediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis] Completed
  6. Phase 2 Faslodex in McCune-Albright Syndrome Completed

Showing the 6 most-cited and recently-updated of 6 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Questions about Precocious Puberty

Are there brain lesions associated with central Precocious Puberty in boys?

While brain lesions were historically common in boys with central precocious puberty (CPP), recent data shows they occur in a much smaller percentage of cases, with most cases being idiopathic.

Full answer →
Does exposure to BPA increase the risk of Precocious Puberty in girls?

Research suggests that exposure to Bisphenol A (BPA) and its substitutes may increase the risk of precocious puberty in girls.

Full answer →